Actively Recruiting

Early Phase 1
Age: 18Years - 59Years
All Genders
Healthy Volunteers
NCT07294092

Ketamine and Propofol NeuroImaging

Led by Keith M Vogt · Updated on 2026-04-15

60

Participants Needed

1

Research Sites

120 weeks

Total Duration

On this page

Sponsors

K

Keith M Vogt

Lead Sponsor

N

National Institute of General Medical Sciences (NIGMS)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a multi-visit which will collect MRI (pictures of the brain) and EEG (brain waves) data to determine changes in brain connectivity and brain activity for memory formation and pain perception while receiving the commonly-used anesthetic agents ketamine and propofol, both alone and in combination.

CONDITIONS

Official Title

Ketamine and Propofol NeuroImaging

Who Can Participate

Age: 18Years - 59Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 18-59 years of age
  • No specific exclusion criteria present
  • Have a valid email address and phone number for the study duration
  • Free from any non-MRI compatible implants
Not Eligible

You will not qualify if you...

  • Pregnant or trying to conceive
  • Body mass index (BMI) greater than 35
  • Significant memory impairment or hearing loss
  • Sleep apnea
  • Chronic pain or frequent pain medication use
  • Chronic medical conditions requiring treatment (hypertension, diabetes, high cholesterol)
  • Neurologic diseases including seizures or tremor
  • Psychiatric diagnoses including anxiety, depression, panic, or PTSD
  • History of abnormal heartbeats, liver or kidney disease, or significant lung disease
  • Severe claustrophobia or intolerance to MRI
  • Metal implants or non-removable metal piercings
  • History of adverse reaction to ketamine or propofol
  • Daily alcohol or heavy alcohol use; history of alcohol abuse
  • Current daily smoker
  • Regular or recent marijuana use (including prescribed/medical marijuana)
  • Illicit drug use
  • Regular use of antiepileptics, antidepressants, antipsychotics, antihistamines, anti-anxiety medications, stimulants, or sleep aids

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15213

Actively Recruiting

Loading map...

Research Team

K

Keith M Vogt, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here